About

The startup develops a real-time health monitoring platform that integrates a multi-analyte biosensor with scalable AI to detect and analyze biomarkers with high precision. This technology enables early disease diagnosis and management by automating health data processing and providing actionable insights to improve patient care and outcomes.

```xml <problem> Current methods for health monitoring often rely on infrequent lab tests, failing to provide continuous, real-time insights into an individual's health status. This lack of continuous data makes it difficult to proactively manage chronic conditions and optimize health and wellness. Existing solutions can also be invasive and inconvenient, hindering widespread adoption. </problem> <solution> Equilibrio is developing an implantable, multi-analyte biosensor coupled with scalable AI to provide continuous, real-time health monitoring. The biosensor, designed for self-implantation, measures multiple biomarkers simultaneously, delivering health data directly to the user without disrupting daily life. Data from the biosensor is processed using AI algorithms to identify trends, detect anomalies, and provide actionable insights. This continuous monitoring approach aims to transform disease diagnosis, treatment, and management, enabling more personalized and proactive healthcare interventions. </solution> <features> - Implantable biosensor with over 200 integrated sensors on a penny-sized device - Continuous monitoring of multiple analytes for comprehensive health insights - CMOS, MEMS, and electrochemical transducer technologies for accurate and reliable measurements - AI-powered data analysis for early disease detection and personalized health recommendations - Wireless data transmission for seamless integration with personal health dashboards - Long-lasting design with a projected lifespan of over one year and no required maintenance - Self-implantable design for ease of use and convenience </features> <target_audience> The primary target audience includes individuals with chronic conditions such as diabetes, patients undergoing GLP-1 treatment, elite athletes, and individuals seeking proactive health and wellness management. </target_audience> ```

What does do?

The startup develops a real-time health monitoring platform that integrates a multi-analyte biosensor with scalable AI to detect and analyze biomarkers with high precision. This technology enables early disease diagnosis and management by automating health data processing and providing actionable insights to improve patient care and outcomes.

Where is located?

is based in Wilmington, United States.

Location
Wilmington, United States
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops a real-time health monitoring platform that integrates a multi-analyte biosensor with scalable AI to detect and analyze biomarkers with high precision. This technology enables early disease diagnosis and management by automating health data processing and providing actionable insights to improve patient care and outcomes.

equilibr.io
Wilmington, United States

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Current methods for health monitoring often rely on infrequent lab tests, failing to provide continuous, real-time insights into an individual's health status. This lack of continuous data makes it difficult to proactively manage chronic conditions and optimize health and wellness. Existing solutions can also be invasive and inconvenient, hindering widespread adoption.

Solution

Equilibrio is developing an implantable, multi-analyte biosensor coupled with scalable AI to provide continuous, real-time health monitoring. The biosensor, designed for self-implantation, measures multiple biomarkers simultaneously, delivering health data directly to the user without disrupting daily life. Data from the biosensor is processed using AI algorithms to identify trends, detect anomalies, and provide actionable insights. This continuous monitoring approach aims to transform disease diagnosis, treatment, and management, enabling more personalized and proactive healthcare interventions.

Features

Implantable biosensor with over 200 integrated sensors on a penny-sized device

Continuous monitoring of multiple analytes for comprehensive health insights

CMOS, MEMS, and electrochemical transducer technologies for accurate and reliable measurements

AI-powered data analysis for early disease detection and personalized health recommendations

Wireless data transmission for seamless integration with personal health dashboards

Long-lasting design with a projected lifespan of over one year and no required maintenance

Self-implantable design for ease of use and convenience

Target Audience

The primary target audience includes individuals with chronic conditions such as diabetes, patients undergoing GLP-1 treatment, elite athletes, and individuals seeking proactive health and wellness management.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.